Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Nelke

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Skeletal Muscle|February 12, 2026
Unveiling FLNC variants: iPSC-derived myogenic cells as a model to study disease mechanismsNassam M Daya, Anne Schänzer, Andreas Hentschel, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Activated Dendritic Cell Subsets Characterize Muscle of Inclusion Body Myositis Patients and Correlate with KLRG1+ and TBX21+ CD8+ T cellsRaphael A Kirou, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Cellular and Molecular Life Sciences : CMLS|August 11, 2022
Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cellsLisa Epping, Christina B Schroeter, Christopher Nelke, et al.
Biological Chemistry|February 12, 2023
Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammationChristina B Schroeter, Christopher Nelke, Marcus Schewe, et al.
Ebiomedicine|July 3, 2024
Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clusteringChristopher Nelke, Christina B Schroeter, Sumanta Barman, et al.
Journal of Neuroinflammation|April 13, 2022
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patientsChristopher Nelke, Frauke Stascheit, Carmen Eckert, et al.
Annals of the Rheumatic Diseases|May 6, 2026
Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markersRaphael A Kirou, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Brain : a Journal of Neurology|April 7, 2025
Mitochondrial damage is associated with an early immune response in inclusion body myositisFelix Kleefeld, Emily Cross, Daniel Lagos, et al.
Journal of Autoimmunity|November 7, 2023
K<sub>2P</sub>2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathiesChristopher Nelke, Thomas Müntefering, Derya Cengiz, et al.
Journal of Autoimmunity|March 5, 2025
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitisSaskia Räuber, Andreas Schulte-Mecklenbeck, Kelvin Sarink, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Skeletal Muscle|February 12, 2026
Unveiling FLNC variants: iPSC-derived myogenic cells as a model to study disease mechanismsNassam M Daya, Anne Schänzer, Andreas Hentschel, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Activated Dendritic Cell Subsets Characterize Muscle of Inclusion Body Myositis Patients and Correlate with KLRG1+ and TBX21+ CD8+ T cellsRaphael A Kirou, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Cellular and Molecular Life Sciences : CMLS|August 11, 2022
Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cellsLisa Epping, Christina B Schroeter, Christopher Nelke, et al.
Biological Chemistry|February 12, 2023
Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammationChristina B Schroeter, Christopher Nelke, Marcus Schewe, et al.
Ebiomedicine|July 3, 2024
Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clusteringChristopher Nelke, Christina B Schroeter, Sumanta Barman, et al.
Journal of Neuroinflammation|April 13, 2022
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patientsChristopher Nelke, Frauke Stascheit, Carmen Eckert, et al.
Annals of the Rheumatic Diseases|May 6, 2026
Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markersRaphael A Kirou, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Brain : a Journal of Neurology|April 7, 2025
Mitochondrial damage is associated with an early immune response in inclusion body myositisFelix Kleefeld, Emily Cross, Daniel Lagos, et al.
Journal of Autoimmunity|November 7, 2023
K<sub>2P</sub>2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathiesChristopher Nelke, Thomas Müntefering, Derya Cengiz, et al.
Journal of Autoimmunity|March 5, 2025
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitisSaskia Räuber, Andreas Schulte-Mecklenbeck, Kelvin Sarink, et al.
Pageof 8